The Hidden Dangers of Winter Sun Exposure – Interview
You may not think about sun safety in the winter…but you should!
Sun safety habits are important
all times of the year, and that includes in the winter. Winter activities, such as snow skiing, can result in significant exposure to ultraviolet (UV) radiation from the sun – the leading cause of skin cancers – as UV rays reflect off surfaces, even on cloudy and hazy days.
This winter, sun exposure may be a special concern as people spend more time outside, due to COVID-19.
Of particular concern is melanoma,
a form of skin cancer. When diagnosed in its early stages, melanoma can be treatable, but it may come back in 20-30% of patients. And in its advanced stages, melanoma can be deadly.
Join me in a recent interview
with Dr. Sigrun Hallmeyer, a Chicago-based oncologist was able to discuss:
- Why sun safety is important all year round
- Warning signs of skin cancer, including melanoma
- The importance of treatment if someone is diagnosed with melanoma
- Treatment options to help prevent a skin cancer called melanoma from coming back after it has been removed by surgery
See the entire interview here:
About Sigrun Hallmeyer
Medical Director of the Cancer Survivorship Center and Medical Director of Oncology Services at Advocate Lutheran General Hospital
Sigrun Hallmeyer was born in Berlin, Germany, and moved to the United States in 1999, where she began her clinical training in Internal Medicine. She completed her fellowship in hematology and medical oncology at the University of Illinois in Chicago in 2005. Today, she is a practicing medical oncologist and hematologist in a large hospital-owned practice located in Park Ridge, IL, a suburb of Chicago. She also serves as an attending physician and teaching faculty member at Advocate Lutheran General Hospital (ALGH).
Dr. Hallmeyer became the medical director of the ALGH Cancer Survivorship Center in 2012, when they opened their doors as the first freestanding on-campus cancer center in Illinois. Dr. Hallmeyer is now the first vice president of the center’s medical staff of about 1,500 associates and assumed the position of medical director of the Cancer Service Line at ALGH in January 2018.
Additionally, Dr. Hallmeyer co-chairs the Russell Institute for Research and Innovation protocol review committee. Her clinical practice focuses on melanoma and immuno-oncology, as well as breast cancer.
*Interview is courtesy: Bristol Myers Squibb